WELL Health Q2 2026 revenue rises 12% as acquisitions and organic growth lift results, company says
Reuters2026/08/06 21:54- For Q2 2026, revenue rose 12% to CAD 400.43 million, driven by organic growth, recent acquisitions, and HEALWELL consolidation.
- Adjusted EBITDA was CAD 48.11 million, down from CAD 49.74 million, as higher operating costs offset gross profit gains.
- Net loss was CAD 7.79 million, reflecting higher interest expense, depreciation and amortization, share-based compensation, and overhead expansion.
- Six-month revenue increased 18% to CAD 768.69 million; patient visits rose 18% to 3.9 million, led by Canada patient services.
- 2026 guidance was raised to CAD 1.58-1.65 billion revenue, CAD 185-195 million Adjusted EBITDA, citing stronger operating performance.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Ivy League’s space gamble: Harvard reveals $2.2 billions SpaceX position, its largest single stock holding
Harvard University Investment Management Company disclosed that it holds $2.2 billion worth of SpaceX shares, making it the largest single stock position in its $4.3 billion US equity portfolio. This holding originated from Harvard’s early investment in SpaceX through venture capital funds, and the position has significantly appreciated after SpaceX’s public listing in June this year. The University of California also disclosed a roughly $1 billion position in SpaceX during the same period. Over the past decade, endowment funds from several universities have made substantial bets on private tech assets.
Circle obtains Major Payment Institution license in Singapore
Crypto prices
More
